Application Note: Quantifying quality attributes of AAV gene therapy vectors by SEC-UV-MALS-dRI
30 March 2020

In this application note, Wyatt Technology describes how a SEC-UV-MALS-dRI workflow can be employed for the measurement of particle concentration, relative capsid content, aggregation, and other quality attributes of AAV-based gene therapy vectors.